Department of Nuclear Medicine, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, 81675, Munich, Germany.
Diagnostic and Interventional Radiology, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, 81675, Munich, Germany.
MAGMA. 2023 Dec;36(6):957-974. doi: 10.1007/s10334-023-01107-w. Epub 2023 Jul 12.
Development of a protocol for validation and quality assurance of filter-exchange imaging (FEXI) pulse sequences with well-defined and reproducible phantoms.
A FEXI pulse sequence was implemented on a 7 T preclinical MRI scanner. Six experiments in three different test categories were established for sequence validation, demonstration of the reproducibility of phantoms and the measurement of induced changes in the apparent exchange rate (AXR). First, an ice-water phantom was used to investigate the consistency of apparent diffusion coefficient (ADC) measurements with different diffusion filters. Second, yeast cell phantoms were utilized to validate the determination of the AXR in terms of repeatability (same phantom and session), reproducibility (separate but comparable phantoms in different sessions) and directionality of diffusion encodings. Third, the yeast cell phantoms were, furthermore, used to assess potential AXR bias because of altered cell density and temperature. In addition, a treatment experiment with aquaporin inhibitors was performed to evaluate the influence of these compounds on the cell membrane permeability in yeast cells.
FEXI-based ADC measurements of an ice-water phantom were performed for three different filter strengths, showed good agreement with the literature value of 1.099 × 10 mm/s and had a maximum coefficient of variation (CV) of 0.55% within the individual filter strengths. AXR estimation in a single yeast cell phantom and imaging session with five repetitions resulted in an overall mean value of (1.49 ± 0.05) s and a CV of 3.4% between the chosen regions of interest. For three separately prepared phantoms, AXR measurements resulted in a mean value of (1.50 ± 0.04) s and a CV of 2.7% across the three phantoms, demonstrating high reproducibility. Across three orthogonal diffusion directions, a mean value of (1.57 ± 0.03) s with a CV of 1.9% was detected, consistent with isotropy of AXR in yeast cells. Temperature and AXR were linearly correlated (R = 0.99) and an activation energy E of 37.7 kJ/mol was determined by Arrhenius plot. Furthermore, a negative correlation was found between cell density (as determined by the reference ADC/f) and AXR (R = 0.95). The treatment experiment resulted in significantly decreased AXR values at different temperatures in the treated sample compared to the untreated control indicating an inhibiting effect.
Using ice-water and yeast cell-based phantoms, a protocol for the validation of FEXI pulse sequences was established for the assessment of stability, repeatability, reproducibility and directionality. In addition, a strong dependence of AXR on cell density and temperature was shown. As AXR is an emerging novel imaging biomarker, the suggested protocol will be useful for quality assurance of AXR measurements within a study and potentially across multiple sites.
制定一种使用具有明确且可重复特性的体模来验证和保证过滤交换成像(FEXI)脉冲序列质量的方案。
在 7T 临床前 MRI 扫描仪上实现了 FEXI 脉冲序列。为了验证序列、验证体模的可重复性以及测量诱导的表观交换率(AXR)变化,建立了三个不同测试类别的六个实验。首先,使用冰水体模研究了不同扩散滤波器下的表观扩散系数(ADC)测量的一致性。其次,利用酵母细胞体模验证了在重复性(相同的体模和扫描)、再现性(不同扫描中单独但可比的体模)和扩散编码方向上的 AXR 确定。第三,此外,还使用酵母细胞体模评估了由于细胞密度和温度改变而导致的潜在 AXR 偏差。此外,还进行了水通道蛋白抑制剂的处理实验,以评估这些化合物对酵母细胞细胞膜通透性的影响。
对三个不同滤过强度的冰水体模进行了基于 FEXI 的 ADC 测量,与文献值 1.099×10mm/s 吻合良好,在各个滤过强度内的最大变异系数(CV)为 0.55%。在单个酵母细胞体模和五次重复的成像会话中进行的 AXR 估计,得到了整体平均值为(1.49±0.05)s,所选感兴趣区域之间的 CV 为 3.4%。对于三个单独制备的体模,AXR 测量结果在三个体模之间的平均值为(1.50±0.04)s,CV 为 2.7%,表明具有高度的再现性。在三个正交扩散方向上,检测到(1.57±0.03)s 的平均值,CV 为 1.9%,表明酵母细胞中 AXR 的各向同性。温度和 AXR 呈线性相关(R=0.99),通过 Arrhenius 图确定了 37.7kJ/mol 的活化能 E。此外,还发现细胞密度(由参考 ADC/f 确定)与 AXR 之间存在负相关(R=0.95)。与未处理的对照相比,处理样品中不同温度下的 AXR 值明显降低,表明存在抑制作用,该结果表明处理实验存在抑制作用。
使用冰水和酵母细胞体模,建立了 FEXI 脉冲序列的验证方案,用于评估稳定性、重复性、再现性和方向性。此外,还表明 AXR 强烈依赖于细胞密度和温度。由于 AXR 是一种新兴的新型成像生物标志物,因此建议的方案将有助于确保研究范围内和跨多个站点的 AXR 测量的质量。